Filing Flows › Omeros (OMER) › Recalls, complaints & regulation
Omeros (OMER): clinical trials
Omeros (OMER) beyond its filings: 2 active clinical trials.
Omeros' latest quarter
Omeros, Q2 2026: revenue $28.5M, operating margin 0.3%, net earnings $13.2M, operating cash flow $4.1M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Omeros have?
2 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.